BROOKS LABORATORIES Share Price

₹ 63.06

+₹2.50 (4.13%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: BROOKS
|
Pharmaceuticals

BROOKS LABORATORIES Share Price Today

As of 2 Nov 2026, BROOKS LABORATORIES share price is ₹63.06. The stock opened at ₹61.80, compared to its previous close of ₹60.56. During today's trading session, BROOKS LABORATORIES share price moved in the range of ₹60.73 to ₹64.50, with an average price of ₹62.61 for the day. Looking at its last 52-week, the stock has touched a low of ₹36.30 and a high of ₹116.00. On the performance front, BROOKS LABORATORIES share price has increased by 13.36% over the last six months and is down 42.79% on a year-on-year basis.

Share price over the last 1 day rose from 60.73 to 63.06, ranging between 60.73 and 64.50.
₹60.73
4.13% up today
₹64.50
1D LOW
1D HIGH

BROOKS LABORATORIES Stock Insights

Latest Earning
Op Profit TrendUp by 351.07% YoY
Latest Earning
Net Profit TrendUp by 346.54% YoY
Latest Earning
Revenue TrendUp by 12.06% QoQ
Stock Performance
OutperformingBeat Nifty by 6.62 % in last 1 month
Shareholding Pattern
DIIDII decreased stake by 100.00%
Shareholding Pattern
FIIFII increased stake by 1150.00%
BROOKS LABORATORIES stock performance
Open₹61.80
High₹64.50
Low₹60.73
Prev. close₹60.56
BROOKS LABORATORIES trading activity
Volume56,146
Average traded price₹63.24
Last traded time03:29:45 02 Nov
Last traded quantity49
Circuit
L
H
₹48.45
₹72.67
52-week
L
H
₹36.30
₹116.00
Mkt Cap Cr
179.25
P/E
13.55
P/B
1.46
ROA
8.92%
ROE
20.04%
ROCE
19.3%
Quick Ratio
1.21
EV/EBITDA
11.53

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Brooks Lab. outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Brooks Lab. appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Brooks Lab. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BROOKS LABORATORIES Company Background

ISIN
INE650L01011
Sector Market Cap
₹ 179.25 Cr

Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company’s segment is Pharmaceutical products, including ingredients and intermediaries. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup, and eye/ear drops. Its products under the Carbapenem category are Imipenem 250 (Milligram) mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. It offers Penicillins in the form of injections, tablets, and dry syrup. Its general category of products includes liquid injections, dry powder injections and eye/ear drops. Its liquid injections include Iron sucrose 100mg/5ml, Iron sucrose 50mg/2.5ml, Phenytoin sodium 50mg/ml and others. Its dry powder injections include Artesunate 60mg, Artesunate 120mg, Omeprazole 40mg, Rabeprazole 20mg, Pantoprazole 40mg and others.

BROOKS LABORATORIES Financial Highlights

  • Revenue: BROOKS LABORATORIES reported revenue of ₹86.91 crore in FY26 vs ₹83.44 crore in FY25. It showed an increase of 4.16% on a yearly basis.
  • Operating Profit: BROOKS LABORATORIES reported an operating profit of ₹24.58 crore in FY26 vs ₹9.79 crore in FY25. It showed an increase of 351.07% on a year-on-year basis.
  • Net Profit: BROOKS LABORATORIES reported a net profit of ₹24.58 crore in FY26 vs ₹9.97 crore in FY25. It showed an increase of 346.54% on a yearly basis.

BROOKS LABORATORIES Quarterly Result Highlights

  • BROOKS LABORATORIES reported revenue of ₹23.14 crore in Jun 2026, compared with ₹20.65 crore in Mar 2026, representing an increase of 12.06% on a quarter-on-quarter (QoQ) basis.
  • BROOKS LABORATORIES reported an operating loss of ₹1.79 crore in Jun 2026, compared with ₹1.52 crore in Mar 2026, representing a decrease of 217.76% on a quarter-on-quarter (QoQ) basis.
  • BROOKS LABORATORIES reported a loss of ₹1.79 crore in Jun 2026, compared with ₹1.52 crore in Mar 2026, reflecting a decrease of 217.76% on a QoQ basis.
  • The earnings per share (EPS) of BROOKS LABORATORIES stood at ₹8.35 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
52.62%
FII
0.04%
Other DII
0.00%
Retail and other
37.44%
Mutual funds
9.90%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.09%
Mar 20260.17%
Jun 20260.00%
Sep 20260.04%

BROOKS LABORATORIES Investment Returns

1 day
+4.79%
1 week
+9.68%
1 month
+15.80%
1 year
-42.79%
3 years
-44.01%
5 years
-47.12%

BROOKS LABORATORIES Share Price History

BROOKS LABORATORIES share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹65.80 / ₹60.56
-5.14%
29 Oct 26
₹61.38 / ₹63.84
+6.58%
28 Oct 26
₹59.55 / ₹59.90
+0.30%
27 Oct 26
₹57.02 / ₹59.72
+3.21%
Show more

BROOKS LABORATORIES Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹85.74₹82.56₹79.49₹63.20
Other Income₹1.17₹0.88₹0.92₹0.21
Total Revenue₹86.91₹83.44₹80.40₹63.42
Total Expenses₹81.10₹80.25₹78.85₹98.83
Profit Before Tax₹24.58-₹9.79-₹19.57-₹38.37
Tax₹0.00₹0.18₹0.03-₹7.32
Profit After Tax₹24.58-₹9.97-₹19.59-₹31.05
EPS - Basic₹8.35-₹3.72-₹7.67-₹12.57
EPS - Diluted₹8.35-₹3.72-₹7.67-₹12.57

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹24.58-₹9.79-₹19.57-₹38.37
Income before WC changes₹7.45₹4.64₹3.08-₹25.76
Change in Assets₹2.51-₹1.71-₹3.78-₹0.33
Change in Liabilities-₹0.73-₹0.81-₹9.29₹11.76
Change in WC₹1.78-₹2.52-₹13.08₹11.43
Cash flow from Operations₹9.29₹2.63-₹9.80-₹14.49
Cash flow from Investing-₹2.92-₹45.14₹0.18₹0.49
Cash flow from Financing₹0.17₹42.43₹9.72₹11.41
Total Cash Flow₹6.54-₹0.08₹0.10-₹2.58
Cash (Start of the year)₹0.04₹0.13₹0.02₹2.61
Cash (End of the year)₹6.59₹0.04₹0.13₹0.02

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹110.76₹89.82₹59.40₹81.99
Current Assets₹37.42₹33.88₹31.05₹27.61
Total Assets₹148.17₹123.69₹90.45₹109.60
Current Liabilities₹21.81₹22.84₹23.05₹33.02
Net Current Asset₹15.60₹11.03₹8.00-₹5.42
Non-Current Liabilities₹3.70₹2.75₹1.81₹2.62
Equity Capital₹122.66₹98.10₹65.59₹73.95
Total Equity & Liabilities₹148.17₹123.69₹90.45₹109.60

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹85.74₹82.56₹79.49₹55.54
Other Income₹1.17₹0.88₹0.92₹0.12
Total Revenue₹86.91₹83.44₹80.40₹55.65
Total Expenses₹81.10₹80.21₹78.85₹63.84
Profit Before Tax₹5.81₹3.23₹1.55-₹8.18
Tax₹0.00₹0.18₹0.03₹0.00
Profit After Tax₹5.81₹3.05₹1.53-₹8.18
EPS - Basic₹1.97₹1.14₹0.58-₹3.32
EPS - Diluted₹1.97₹1.14₹0.58-₹3.32

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹5.81₹3.23₹1.55-₹8.18
Income before WC changes₹7.45₹4.64₹3.08-₹5.43
Change in Assets₹2.51-₹1.71-₹3.78₹9.54
Change in Liabilities-₹0.73-₹0.81-₹9.29-₹3.37
Change in WC₹1.78-₹2.52-₹13.08₹6.17
Cash flow from Operations₹9.29₹2.63-₹9.80₹0.55
Cash flow from Investing-₹2.92-₹45.14₹0.18-₹0.40
Cash flow from Financing₹0.17₹42.43₹9.72-₹0.21
Total Cash Flow₹6.54-₹0.08₹0.10-₹0.06
Cash (Start of the year)₹0.04₹0.13₹0.02₹0.08
Cash (End of the year)₹6.59₹0.04₹0.13₹0.02

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹108.95₹106.78₹63.34₹64.82
Current Assets₹37.42₹33.88₹31.05₹27.61
Total Assets₹146.36₹140.66₹94.39₹92.42
Current Liabilities₹21.81₹22.84₹23.05₹33.02
Net Current Asset₹15.60₹11.03₹8.00-₹5.42
Non-Current Liabilities₹3.70₹2.75₹1.81₹2.62
Equity Capital₹120.84₹115.07₹69.53₹56.78
Total Equity & Liabilities₹146.36₹140.66₹94.39₹92.42
* All values are in INR Crore
BROOKS LABORATORIES market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
BROOKS LABORATORIES technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.47
Neutral
ATR (14)
5.53
Neutral
STOCH(9,6)
36.4
Neutral
STOCH RSI (14)
25.98
Neutral
ADX(9)
19.78
Bullish
UO(9)
37.9
Neutral
ROC(12)
-6.49
Bearish
WillR(14)
-71.81
Neutral
Period
Simple value
Exponential vaue
5D
60.38
61.07
10D
61.43
61.52
20D
62.54
61.92
50D
62.34
62.38
100D
64.57
63.15
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct1L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

BROOKS LABORATORIES
Pharmaceuticals
Add Stock
Add Another

BROOKS LABORATORIES Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

BROOKS LABORATORIES Share Price FAQs

Please be aware that BROOKS LABORATORIES stock prices are subject to continuous fluctuations due to various factors.